hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06323083 id: 006 briefTitle: The Effect of Emotional Freedom Technique on Perceived Stress and General Self-Efficacy in Nursing Students overallStatus: COMPLETED date: 2022-11-07 date: 2022-11-28 date: 2023-06-30 date: 2024-03-21 date: 2024-03-21 name: Selcuk University class: OTHER briefSummary: The study was conducted to determine the effect of Emotional Freedom Technique (EFT) on perceived stress and general self-efficacy in obstetrics and gynecology nursing lesson in undergraduate nursing students with fear of birth.
The samples were applied to undergraduate nursing students satisfying the research criteria in a state university nursing faculty in Konya at November 2022. conditions: Emotion Regulation conditions: Stress conditions: Self Efficacy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The study was designed to be randomly controlled. primaryPurpose: SUPPORTIVE_CARE masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 50 type: ACTUAL name: Emotional Freedom Technique measure: General Self-Efficacy Scale measure: Perceived Stress Scale measure: The Subjective Units of Distress Scale sex: FEMALE minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: Selcuk University city: Konya country: Turkey lat: 37.87135 lon: 32.48464 hasResults: False
nctId: NCT06323070 id: HS-2023-0281 briefTitle: Effects of Watermelon or Low-fat Cookie Consumption on Wellness overallStatus: RECRUITING date: 2024-03-01 date: 2025-12 date: 2025-12 date: 2024-03-21 date: 2024-03-22 name: San Diego State University class: OTHER briefSummary: The objective of the proposed research is to determine the effects of fresh watermelon consumption on physiological indicators of wellness regarding sexual, skin and gut health in adults. conditions: Overweight and Obesity studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER primaryPurpose: PREVENTION masking: NONE count: 80 type: ESTIMATED name: Low-fat cookies name: Watermelon measure: Change of sexual health questionnaire scores measure: Change of skin hydration scores measure: Change of microbiome diversity measure: Change of depression questionnaire scores sex: ALL minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: School of Exercise and Nutritional Sciences status: RECRUITING city: San Diego state: California zip: 92182 country: United States name: Mee Young Hong, PhD role: CONTACT phone: 619-594-2392 email: mhong2@sdsu.edu lat: 32.71533 lon: -117.15726 hasResults: False
nctId: NCT06323057 id: Pro2022000444_CLFMT briefTitle: Modulating Reward Learning Using Transcranial Magnetic Stimulation overallStatus: RECRUITING date: 2024-02-14 date: 2025-04-30 date: 2025-04-30 date: 2024-03-21 date: 2024-03-22 name: Rutgers, The State University of New Jersey class: OTHER briefSummary: Our specific aim is to examine the effects of TMS on reward processing during goal-directed behavior. In these experiments the investigators will utilize a scalp-recorded brain oscillation called frontal midline theta that is believed to index the sensitivity of the cingulate cortex to reward feedback. Here the investigators will asked whether this electrophysiological signal can be modulated up or down using TMS while participants engage in decision making tasks, and if so, whether it would affect the encoding of rewards and subsequent choices during task performance. conditions: Behavior studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: BASIC_SCIENCE masking: SINGLE maskingDescription: Participants will be blinded to the TMS condition (active or sham) whoMasked: PARTICIPANT count: 28 type: ESTIMATED name: Single pulse TMS to the frontal cortex measure: Event-related Brain Oscillation: Frontal Midline Theta measure: Reward learning sex: ALL minimumAge: 18 Years maximumAge: 55 Years stdAges: ADULT facility: Rutgers University - Newark status: RECRUITING city: Newark state: New Jersey zip: 07102 country: United States name: Travis E Baker, PhD role: CONTACT phone: 862-250-3351 email: travis.e.baker@rutgers.edu name: Daniel Robles, PhD role: CONTACT phone: 973-353-3509 email: dr1147@newark.rutgers.edu lat: 40.73566 lon: -74.17237 hasResults: False
nctId: NCT06323044 id: I-3920723 id: NCI-2024-01734 type: REGISTRY domain: CTRP (Clinical Trial Reporting Program) id: I-3920723 type: OTHER domain: Roswell Park Cancer Institute id: R01CA283501 type: NIH link: https://reporter.nih.gov/quickSearch/R01CA283501 briefTitle: MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence overallStatus: NOT_YET_RECRUITING date: 2024-06-15 date: 2029-06-15 date: 2029-06-15 date: 2024-03-21 date: 2024-04-03 name: Roswell Park Cancer Institute class: OTHER briefSummary: This clinical trial identifies and addresses barriers to pediatric medication adherence among families of children with acute lymphoblastic leukemia. Pediatric nonadherence (noncompliance) to medication is a significant public health problem, and rigorous research repeatedly documents that nonadherence increases risk for hospitalization, healthcare cost, disease progression, and death. Pediatric acute lymphoblastic leukemia (ALL) patients who miss 5% of 6-mercaptopurine (6-MP) doses within the 2-year 6-MP regimen have a 2.7-fold risk of cancer that comes back after a period of improvement (relapse). To address these families' needs, researchers have developed MedSupport, a theory-based multilevel intervention with targets at the organizational, healthcare team, and caregiver levels that is designed to address root barriers to medication adherence. This study is being done to better understand families' experiences giving their child oral chemotherapy at home and to help families cope with the day-to-day challenges of giving their child medication. conditions: Acute Lymphoblastic Leukemia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 150 type: ESTIMATED name: Best Practice name: Biospecimen Collection name: Electronic Health Record Review name: Interview name: Medical Device Usage and Evaluation name: Medical Device Usage and Evaluation name: Survey Administration measure: Medication adherence sex: ALL minimumAge: 365 Days stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Roswell Park Cancer Institute city: Buffalo state: New York zip: 14263 country: United States name: Kara M. Kelly role: CONTACT phone: 716-845-2333 email: Kara.Kelly@RoswellPark.org name: Kara M. Kelly role: PRINCIPAL_INVESTIGATOR lat: 42.88645 lon: -78.87837 hasResults: False
nctId: NCT06323031 id: Blink-DoC briefTitle: Spontaneous Eye Blinking in Disorders of Consciousness acronym: Blink-DoC overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2025-05 date: 2025-11 date: 2024-03-21 date: 2024-03-21 name: Fondazione Don Carlo Gnocchi Onlus class: OTHER name: Therapiezentrum Burgau name: University of Liege name: University Hospital Munich name: VITHAS Valencia (Spain) name: Azienda Ospedaliera Universitaria Ferrara name: Ludwig-Maximilians - University of Munich briefSummary: Differential diagnosis between Unresponsive Wakefulness Syndrome (UWS) and Minimally Conscious State (MCS) is complicated due to severe cognitive and/or sensorimotor deficits in these patients. In this study the investigators aimed at exploring the diagnostic and prognostic validity of spontaneous eye blinking parameters (rate, amplitude, duration, variability) in a sample of patients with Disorders of Consciousness (DoC).
nctId: NCT06323018 id: 384T-26 briefTitle: Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty. acronym: PRINCIPAL overallStatus: RECRUITING date: 2024-03-20 date: 2026-03 date: 2027-03 date: 2024-03-21 date: 2024-04-04 name: University of Tartu class: OTHER briefSummary: Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients. conditions: Osteoarthritis, Hip conditions: Cardiovascular Diseases conditions: Bone Cement Implantation Syndrome conditions: Kidney Diseases studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: QUADRUPLE maskingDescription: Randomization and intervention is done by a dedicated study nurse. Patient, orthopedic surgeon, investigator and outcomes assessor and statistician are all blinded to the study intervention. whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 200 type: ESTIMATED name: Remote Ischemic Preconditioning name: SHAM measure: Myocardial injury measure: Cardiovascular injury measure: Clinical serious complications measure: Carotid-femoral pulse velocity measure: Augmentation index measure: Brain injury measure: Kidney Injury measure: Total antioxidative capacity (TAC) measure: Oxidative stress level (total peroxide levels) measure: Inflammation level measure: Low molecular weight metabolites (uM) sex: ALL minimumAge: 65 Years maximumAge: 90 Years stdAges: OLDER_ADULT facility: University of Tartu status: RECRUITING city: Tartu state: Tartumaa zip: 50406 country: Estonia name: Kaspar Tootsi, MD, PhD role: CONTACT phone: +3727318282 email: kaspar.tootsi@kliinikum.ee lat: 58.38062 lon: 26.72509 hasResults: False
nctId: NCT06322992 id: R41CA271962 type: NIH link: https://reporter.nih.gov/quickSearch/R41CA271962 briefTitle: App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3 overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-05 date: 2025-05 date: 2024-03-21 date: 2024-03-22 name: Daynamica, Inc. class: INDUSTRY name: Masonic Cancer Center, University of Minnesota briefSummary: The goal of this observational study is to develop a mobile app for cancer patients undergoing treatments. In Aim 3, patients will rate the quality of the app using the Mobile App Rating Scale (MARS) and their satisfaction with the three key app features. The outcome of this project will be a final prototype app with 70% of patients indicating an overall MARS score of 4.0 or more and satisfaction with the three features. conditions: Cancer studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 60 type: ESTIMATED measure: APP satisfaction measure: APP rating sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06322979 id: # R-PED-11-23-3074 briefTitle: Premixed Bioceramic Putty as an Apical Plug in Immature Anterior Permanent Teeth overallStatus: RECRUITING date: 2023-11-22 date: 2024-11 date: 2024-12 date: 2024-03-21 date: 2024-03-21 name: Tanta University class: OTHER briefSummary: Following the randomization procedure, children will be divided into 2 groups (25 immature anterior permanent incisors in each group): Group I will be treated with MTA as apical plug while group II will be treated with Premixed Bioceramic Putty as apical plug. After working length determination, instrumentation, and irrigation of the root canals, apical plug will be done. in MTA Group, MTA will be placed into the apical 4 mm of root canals, then a moist cotton pellet will be placed and the access cavity will be restored with glass-ionomer-based restoration. Next day, glass-ionomer-based restoration and the cotton pellet will be removed, then the coronal restoration will be completed with GIC, composite. In the Premixed Bioceramic Putty group, Well-Root™ PT will be placed into the apical 4 mm of the canals. After 12 min, the coronal and middle third of the root canal will be filled with gutta-percha. The coronal restoration will be completed with GIC, composite.
children will be recalled for clinical and radiographical follow-up after 6 and12 months after treatment. conditions: Periapical Periodontitis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 50 type: ESTIMATED name: Mineral trioxide aggregate name: Premixed Bioceramic Putty measure: the clinical success of apexification after using a new apical plug material (Premixed Bioceramic Putty ) compared to the widely used material (MTA) measure: the radiographic success of apexification after using a new apical plug material (Premixed Bioceramic Putty ) compared to the widely used material (MTA) measure: Change in the periapical index (PAI) sex: ALL minimumAge: 8 Years maximumAge: 11 Years stdAges: CHILD facility: Tanta University status: RECRUITING city: Tanta state: Gharbia zip: 6624033 country: Egypt name: Shaimaa eldesouky, PhD role: CONTACT phone: 01008994242 email: shiamaaeldesouky@dent.tanta.edu.eg name: mohamed ghaly, PhD role: CONTACT phone: 01098472899 lat: 30.78847 lon: 31.00192 hasResults: False
nctId: NCT06322966 id: STUDY00017745 id: K99ES034442 type: NIH link: https://reporter.nih.gov/quickSearch/K99ES034442 briefTitle: Learning and Living With Wildfire Smoke overallStatus: RECRUITING date: 2023-09-04 date: 2027-05-28 date: 2028-05-26 date: 2024-03-21 date: 2024-03-21 name: University of Washington class: OTHER name: National Institute of Environmental Health Sciences (NIEHS) briefSummary: The proposed intervention in this Youth Participatory Action Research (YPAR) proposal will improve knowledge and awareness of the health impacts of air pollution exposure, will elevate the youth voice, improve youth self-efficacy and lead to behavior changes that would reduce exposure to air pollution in a high school setting. These outcomes will be accomplished through the introduction of a new air quality curriculum, called AirActions, into freshman science classes, and the establishment of an after-school air quality monitoring program.
All students enrolled in freshman Honors Biology (Pueblo East and Montrose High Schools), Intro to Agriculture (The STEAD School) and Environmental Science (Grand Junction High School) will participate in the new air quality curriculum, as it will be built into the existing lesson plans. For the after-school monitoring program, the PI and participating teachers (Letters A and B) will recruit 10 to 15 students at each school to be involved in the Student Research Cohort (SRC). Information on this program and how to apply will be shared with students through their health and science classes, included in the school newsletter, and posted on billboards around the school. Students will be identified within the following inclusion criteria: 1) freshman or sophomores in high school and 2) participation in the AirActions curriculum. New students will be recruited each year to keep a consistent group as students leave and/or graduate. New students will be brought up to speed by carry-over students, and each new year will represent a separate SRC dedicated to a specific goal. conditions: Behavior and Behavior Mechanisms conditions: Health Knowledge, Attitudes, Practice studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: OTHER masking: NONE count: 400 type: ESTIMATED name: Air Action Curriculum measure: Number of students, staff, teacher and administrators with higher scores on a Likert-style questionnaire for content knowledge learning objectives. measure: Scores on Likert-style questionnaire to evaluate behavior change around air quality. measure: Change in student exposure to air pollution calculated through measurements of indoor particulate matter and indoor carbon dioxide. sex: ALL minimumAge: 14 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: University of Washington status: RECRUITING city: Seattle state: Washington zip: 98195 country: United States name: Savannah M D'Evelyn, PhD role: CONTACT phone: 303-501-6656 email: sdevelyn@uw.edu lat: 47.60621 lon: -122.33207 hasResults: False
nctId: NCT06322953 id: RG442-21 briefTitle: Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage acronym: RESTARTtlCrH overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2027-12-31 date: 2028-07-31 date: 2024-03-21 date: 2024-03-22 name: Walton Centre NHS Foundation Trust class: OTHER name: University of Liverpool name: National Institute for Health Research, United Kingdom briefSummary: Older people falling from a standing height is the most common cause of hospital admission for head injury. Up to 1 in 3 patients admitted are taking a tablet medication which thins the blood, known as an oral anticoagulant. This type of medication can increase the likelihood of bleeding in the brain. Many patients are taking oral anticoagulation due to having an irregular heartbeat (called atrial fibrillation) or because of having a previous stroke or blood clots. When a scan shows blood in the brain, oral anticoagulation is nearly always stopped. However, this leaves the question of when it is safe to restart them. The risk of making the bleeding in the brain worse must be balanced against the risk of having a stroke or blood clots. There is no clear evidence on the safest time to restart oral anticoagulation, but most neurosurgeons advise restarting them 1-4 weeks after head injury. The number of people who have a bleed on their brain after a head injury is increasing and further brain bleeding or a stroke can have a serious effect on patients' lives and their on-going healthcare needs. Public and patient groups have highlighted that many patients want to stop taking oral anticoagulation after a bleed but they may be unaware of the vital importance of restarting this medication to prevent strokes and blood clots. The most popular oral anticoagulation prescribed has changed in recent years from warfarin to newer medications called Direct Oral Anti-Coagulants (DOACs).
This trial will recruit 1084 people who are admitted to hospital with a bleed on the brain caused by a head injury who were taking oral anticoagulation before their head injury and have been prescribed a Direct Oral Anti-Coagulant (DOAC) for previously diagnosed medical condition. Patients on other Oral Anti-Coagulants, such as Warfarin may also be able to take part. The main purpose of the trial is to determine when is most beneficial time for people to start or restart a DOAC after their head injury. People will be asked to start the medication either 1 week or 4 weeks after their head injury. They will be then followed closely for 12 weeks and any major bleeding events or a blood clots (thrombotic events) such as a stroke or heart attack will be recorded. The study will also look at the person's overall quality of life, how they recover physically, the number of people who die, the costs of the treatment, and the attitudes of people and their caregivers to starting or restarting a DOAC. conditions: Traumatic Intracranial Haemorrhage studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomised Controlled Trial primaryPurpose: TREATMENT masking: NONE count: 1084 type: ESTIMATED name: Direct-Acting Oral Anticoagulants (used as per local standard practice) measure: Proportion of patients with haemorrhagic or thrombotic event within 12 weeks following tICrH. measure: Time to first haemorrhagic or thrombotic event. measure: Time to first haemorrhagic event measure: Time to first thrombotic event measure: Time to death measure: Functional outcome measured using modified Rankin Scale (mRS) measure: Functional outcome measured using Barthel Index measure: Functional outcome measured using extended Glasgow Outcome Scale (GOS-E) measure: Overall Quality of Life measured by EuroQol 5 Dimensions 5 Levels (EQ5D5L) questionnaire measure: Patient/caregiver attitudes to (re)starting OAC measure: Healthcare resource use sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06322940 id: 2024-10463 briefTitle: Effect of Dairy Product Matrices on Insulin Resistance in People With Overweight and Obesity and Prediabetes overallStatus: NOT_YET_RECRUITING date: 2024-09-01 date: 2026-09-01 date: 2026-12-31 date: 2024-03-21 date: 2024-03-21 name: McGill University Health Centre/Research Institute of the McGill University Health Centre class: OTHER name: Dairy Farmers of Canada briefSummary: The objective of the study is to determine the effect of dairy product matrices on insulin sensitivity in overweight and obese adults with prediabetes. Females and males (30-65 y) will be recruited from the greater Montreal area. Upon screening, those with prediabetes will complete a 2-wk run-in period in which participants will consume 1 serving/d of regular-fat dairy products (milk, yogurt, or cheese). Adherent participants will be randomized by sex into 1 of 3 groups: ≤1 serving/d of dairy (limited dairy) or 2-3 servings/d of reduced-fat or regular-fat dairy for 12 weeks. Participants will be instructed on how to incorporate foods into their diet to prevent changes in their body weight. The hyperinsulinemic-euglycemic clamp will be used before and after the intervention to document potential changes in insulin sensitivity as the primary outcome. In addition, glycemic variables, body composition, and cardiometabolic risk factors will be assessed as secondary outcomes. Adherence to intervention will be assessed at each visit by food diaries and a record of consumed dairy products. conditions: PreDiabetes conditions: Overweight and Obesity studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Three treatment groups primaryPurpose: OTHER masking: DOUBLE maskingDescription: Participant's study group will be coded. whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: 250 mL serving size, 3.25% fat content name: 175 g serving size, ≥2% fat content name: 50 g serving size, ≥28% fat content measure: Change in whole-body insulin sensitivity measure: Change in glucose tolerance measure: Change in Matsuda index measure: Change in Insulinogenic index measure: Change in oral disposition index measure: Change in Homeostatic Model Assessment for Insulin Resistance measure: Change in glycated hemoglobin measure: Change in total lean body mass measure: Change in total fat mass measure: Change in visceral fat mass measure: Change in systolic blood pressure measure: Change in diastolic blood pressure measure: Change in lipid profile measure: Change in resting energy expenditure measure: Change in total energy expenditure measure: Change in metabolic equivalent of task measure: Change in total energy intake sex: ALL minimumAge: 30 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: RI-MUHC city: Montréal state: Quebec zip: H4A 3J1 country: Canada lat: 45.50884 lon: -73.58781 hasResults: False